Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by JDavenporton Jan 04, 2021 11:53am
309 Views
Post# 32215453

Cellphone Troubles

Cellphone TroublesMy cellphone is on the fritz and I have no touchscreen reponse. It's an almost normal touchscreen except there's no touch. I can't remember whether I dropped it from the upper deck or ate it in a panini. As a result I can neither read nor respond to text and WhatsApp messages. I have parts for my old phone on the way and I have a new, unlocked 400 HP V8 sports job on order, complete with two-way sneeze-through wind vents, due by the end of the week.

So, I can take calls via headset, and I can take messages by email, but no texts or WhatApp messages, which, like beautiful young women, I can see they're there but I have no access to them.

So, interesting things coming, I am well rested and I'm looking forward to seeing this unfold in 2021. Website is imminent. I won't have a lot of time available this week, so call, if you must, we can have a short chat, but it's going to be a busy for me.

digitel, or prophetofobviousfacts (poof), has posted that old (Dec 16) news about Neuron23. Neuron23 goes on a list of the many things that are interesting to watch. It's made the news this time because it raised a lot of money, which they'll need to fund their R&D, something that's quite different at Bioasis because Bioasis deals in proven payloads. I have looked at N23, looks like Saltarelli is no longer involved, and I may have something to say if they offer up any serious scientific news. 

Happy New Year everybody!

jd
jd@stoxcomm.com
250-255-8442
<< Previous
Bullboard Posts
Next >>